Essentials: Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson

Welcome to Huberman Lab Essentials, where we revisit past episodes for the most potent and actionable science-based tools for mental health, physical health, and performance. I'm Andrew Huberman and I'm a professor of neurobiology and ophthalmology at Stanford School of Medicine. And now my conversation with Dr. Matthew Johnson. Well, Matthew, I've been looking forward to this for a long time.

I'm a huge fan of your scientific work and I'm eager to learn from you. Likewise, big fan and happy to do this with you. Great. Well, thank you.

My first question is a very basic one, which is what qualifies a substance to as a psychedelic? Nomenclature is a real challenge in this area of psychedelics. So starting with the word psychedelic, it just if if you're a pharmacologist, it's it's not very satisfying because that term really spans different pharmacological classes. In other words, if you're really concerned about receptor effects and the basic effects of a compound, it spans several com classes of compounds.

We already have this episode, so unlocking it is cheap and permanent: the full transcript (39 minutes, 6,694 words), segment and word-level timestamps, and .txt, .srt, .vtt and word-level JSON downloads, as many times as you like, forever.

No account needed, we create one from your checkout email. With credits it is 1 credit; packs start at 10 episodes for $5, and monthly plans are cheaper still.